Showing results (931-940 of 2,578) with videos related to

Sort By:
Pageof 258
Molecular Oncology|November 20, 2020
How to make better use of scientific knowledge for cancer preventionPekka Puska
Molecular Oncology|November 7, 2020
KMT2C promoter methylation in plasma-circulating tumor DNA is a prognostic biomarker in non-small cell lung cancerSofia Mastoraki, Ioanna Balgkouranidou, Emily Tsaroucha, et al.
Molecular Oncology|September 5, 2020
Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility - a prospective, translational studyDorte S Nørøxe, Christina W Yde, Olga Østrup, et al.
Molecular Oncology|September 6, 2020
Interaction of BACH2 with FUS promotes malignant progression of glioma cells via the TSLNC8-miR-10b-5p-WWC3 pathwayYang Yang, Xiaobai Liu, Jian Zheng, et al.
Molecular Oncology|September 8, 2020
Cationic amphiphilic drugs as potential anticancer therapy for bladder cancerGeertje van der Horst, Arjanneke F van de Merbel, Eline Ruigrok, et al.
Molecular Oncology|November 25, 2020
Multiplex RNA-based detection of clinically relevant MET alterations in advanced non-small cell lung cancerCristina Aguado, Cristina Teixido, Ruth Román, et al.
Molecular Oncology|December 12, 2019
Targeting claudin-overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxinAnna Piontek, Miriam Eichner, Denise Zwanziger, et al.
Molecular Oncology|March 6, 2020
Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastomaThomas Urup, Linn Gillberg, Katja Kaastrup, et al.
Molecular Oncology|January 20, 2020
CCL5 mediates target-kinase independent resistance to FLT3 inhibitors in FLT3-ITD-positive AMLSilvia Waldeck, Michael Rassner, Philip Keye, et al.
Molecular Oncology|January 20, 2020
Metabolism-associated molecular classification of hepatocellular carcinomaChen Yang, Xiaowen Huang, Zhicheng Liu, et al.
Pageof 258